Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Firms Sift Eye Study Data For Benefit From Lutein And Zeaxanthin

This article was originally published in The Tan Sheet

Executive Summary

After the Age-Related Eye Disease Study found lutein, zeaxanthin and omega-3s do not slow age-related macular degeneration, supplement firms revisit the data and find lutein and zeaxanthin could slow the disease in deficient populations.

Advertisement

Related Content

Vision Health Supplements Blurry On AREDS Formulation – Study
New Products In Brief: MacuDrop, Clearwayz, Adiri MD+ and more
Bausch + Lomb Buy Vaults Valeant Into Consumer Eye Care Space
Carotenoids, Anitoxidants Improve Treatment For AMD – Study
Researchers Eye Lutein, Zeaxanthin, Vitamin E To Reduce Cataracts
Industry, Researchers Pan Study Showing Antioxidants May Up Mortality Risk
Bausch & Lomb OcuVite Line Extension Used In Natl. Eye Institute Study

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS106403

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel